Browse
Drugs
Categories
Pathways
Drug Reactions
Drug Classification
Drug Targets
Pharmaco-genomics
Pharmaco-metabolomics
Pharmaco-transcriptomics
Pharmaco-proteomics
COVID-19
Search
Chemical Structure
Molecular Weight
Drug & Food Interactions
Target Sequences
Pharmaco-omics
Advanced Search
MS Search
MS/MS Search
GC/MS Search
1D NMR Search
2D NMR Search
Downloads
Commercial Data
Products
Clinical Drug Data
Scientific Drug Data
Industries
Drug Discovery
Drug Repurposing
Precision Medicine
Machine Learning
Telehealth
Resources
White Papers
Help
Help Center
Quick Links
Citing DrugBank
DrugBank Online FAQs
Searching DrugBank
Other Databases
Data Sources
About
About DrugBank Online
DrugBank in Research
Statistics
Blog
Wishart Research Group
Contact Us
Drugs
Targets
Pathways
Indications
Prolonged Apnea Completed Phase Trials for Acetaminophen (DB00316)
Back to Prolonged Apnea
Indication
Status
Phase
DBCOND0037545 (Prolonged Apnea)
Completed
Not Available
clinicaltrials.gov Identifier
Title
Purpose
Drugs
NCT00482781
DTaP and Apnea/Bradycardia in Preterm Infants
Prevention
Acetaminophen (DB00316)
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788)
Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992)
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991)
Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)